台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

NDP030: Lower urinary tract symptom improvement in enlarged prostate patient failing to other a-blockers after silodosin treatment silodosin

2017-06-04 • 觀看: 1932 • 回應: 0 • doc
NDP029: Is maximum urine flow rate of less than 15ml/sec a risk factor of urine retention

2017-06-04 • 觀看: 2122 • 回應: 0 • doc
NDP028: Treatment outcomes of benign prostatic enlargement by laser vaproresection of the prostate (multipulse thulium+1470 laser system)

2017-06-04 • 觀看: 1995 • 回應: 0 • doc
NDP027: Clinical result of 5-alpha-reductase inhibitor therapy in Taiwan

2017-06-04 • 觀看: 1968 • 回應: 0 • doc
NDP026: Traditional chinese medicine therapy reduces dysuria in dementia patients

2017-06-04 • 觀看: 1997 • 回應: 0 • doc
NDP025: Recurrent of transitional cell carcinoma in an ileal conduit: A case report and literature review

2017-06-04 • 觀看: 2548 • 回應: 0 • doc
NDP024: Urothelial carcinoma of urinary bladder, giant cell type: Case report and literature review

2017-06-04 • 觀看: 2054 • 回應: 0 • doc
NDP022: Invasive bladder cancer under neoadjuvant concurrent chemo-radiotherapy with palliative TUR-BT: A case report

2017-06-04 • 觀看: 1964 • 回應: 0 • doc
NDP021: Carcinosarcoma of the bladder: A case report of rare type bladder cancer

2017-06-04 • 觀看: 1908 • 回應: 0 • doc
NDP020: Reversine induces autophagic cell death through the AMPK pathway in urothelial carcinoma cells

2017-06-04 • 觀看: 1948 • 回應: 0 • doc
NDP019: Demographic shift in patients underwent radical cystectomy in management of bladder urothelial carcinoma: A 20-year review

2017-06-04 • 觀看: 1918 • 回應: 0 • doc
NDP018: The gender difference and mortality-to-incidence ratio relate to health care disparities in bladder cancer: national estimates from 33 countries

2017-06-04 • 觀看: 1817 • 回應: 0 • doc